Citizens National Bank Trust Department’s Devon Energy DVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
25,980
+545
+2% +$25.3K 0.16% 112
2026
Q1
$1.28M Buy
25,435
+6,662
+35% +$286K 0.21% 103
2025
Q4
$688K Sell
18,773
-1,287
-6% -$44.9K 0.12% 129
2025
Q3
$703K Sell
20,060
-221
-1% -$7.52K 0.13% 122
2025
Q2
$645K Sell
20,281
-1,102
-5% -$35.1K 0.13% 122
2025
Q1
$800K Sell
21,383
-5,616
-21% -$199K 0.17% 108
2024
Q4
$884K Buy
26,999
+510
+2% +$19.2K 0.19% 106
2024
Q3
$1.04M Buy
26,489
+4,725
+22% +$208K 0.22% 102
2024
Q2
$1.03M Buy
21,764
+5,845
+37% +$291K 0.23% 97
2024
Q1
$799K Buy
15,919
+5,009
+46% +$222K 0.19% 99
2023
Q4
$494K Buy
+10,910
New +$499K 0.13% 121

Other funds holding DVN

Citizens National Bank Trust Department's DVN Position: Q2 2026 in Review

Citizens National Bank Trust Department increased its Devon Energy (DVN) stake by 2.1% in Q2 2026, buying an estimated $25.3K and bringing the position to 25,980 shares worth $1.07M. The position accounts for 0.16% of the portfolio, ranked #112.

Citizens National Bank Trust Department first reported a position in DVN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.28M in Q1 2026. 1,458 funds tracked by Wall St. Rank hold DVN as of Q2 2026.

  • Citizens National Bank Trust Department held 25,980 shares of Devon Energy worth $1.07M as of Q2 2026.
  • Citizens National Bank Trust Department bought 545 Devon Energy shares in Q2 2026, an estimated $25.3K.
  • Devon Energy made up 0.16% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #112 holding.
  • Citizens National Bank Trust Department first reported a position in Devon Energy in Q4 2023 and has held it in 11 quarters since.
  • Citizens National Bank Trust Department's Devon Energy position peaked at $1.28M in Q1 2026.
  • 1,458 funds tracked by Wall St. Rank held Devon Energy as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.